Protecting tissue (bioprosthetic) heart valves in people with metabolic syndrome
Official title: Mitigation Strategies for Metabolic Syndrome-induced Bioprosthetic Heart Valve Degeneration
Funded at Columbia University Health Sciences · NIH-11296840 · Data updated 2026-11-12
This project tries a special polymer coating to help tissue heart valves last longer in people with metabolic syndrome or type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 10, 2024 |
| Project end | February 28, 2029 |
| Funding year | 2026 |
| Award (this year) | $749,115 |
| NIH project number | 5R01HL170573-03 |
| Project ID | NIH-11296840 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with metabolic syndrome or type 2 diabetes who need or already have a bioprosthetic (tissue) heart valve are the most relevant candidates for this work.
✕Less likely to help
People with mechanical heart valves, valve problems not related to metabolic syndrome, or who are not eligible for bioprosthetic valves are unlikely to benefit directly from this work.
What this research studies
I have a tissue (bioprosthetic) heart valve that can wear out faster if I have metabolic syndrome or diabetes. The team is testing a polymer called poly-2-methyl-2-oxazoline (POZ) applied to valve tissue to reduce protein sticking, sugar-related damage, oxidation, and calcium buildup. They will run lab tests using human serum, biochemical assays, and implants in Zucker diabetic fatty rats to see whether the coating lowers damage and calcification. If these experiments succeed, the approach could move toward use on surgical and transcatheter tissue valves for patients like me.
Why it matters
Potential benefit: If successful, the coating could make tissue heart valves last longer in patients with metabolic syndrome, reducing the need for repeat valve procedures.
How similar studies have gone: Early laboratory tests and rat-model experiments from this group have shown the POZ coating reduces protein damage and calcification, but the approach has not yet been tested in human clinical trials.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Ferrari, Giovanni — Columbia University Health Sciences
- Study coordinator: Ferrari, Giovanni
Related research
Other NIH-funded projects on the same topics.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Metabolic syndrome and brain support cells: how it may lead to Alzheimer’s disease
A researcher is studying how midlife metabolic problems like diabetes and obesity may disrupt brain cells that support neurons, potentially leading to Alzheimer's disease and related dementia in later life.
-
GLP-1 medicines to improve heart, kidney, and metabolic health for people with HIV and type 2 diabetes
A real-world study will look at how GLP-1 receptor agonists affect heart and kidney health and lifetime costs for people living with HIV and type 2 diabetes.
-
A new metabolic risk score to predict heart disease in Yup’ik Alaska Native adults
A new, questions-free way to measure heart-disease risk in Yup’ik Alaska Native adults by combining everyday health clues with home-life factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.